We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-2.43%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$500M
AUM Growth
-$80.8M
Cap. Flow
-$34.9M
Cap. Flow %
-6.99%
Top 10 Hldgs %
34.04%
Holding
671
New
64
Increased
221
Reduced
213
Closed
46

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$9.36M
2
MT icon
ArcelorMittal
MT
+$8.22M
3
T icon
AT&T
T
+$7.11M
4
BUD icon
AB InBev
BUD
+$5.34M
5
BCE icon
BCE
BCE
+$4.96M

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.51%
2 Communication Services 11.94%
3 Materials 10.5%
4 Consumer Discretionary 9.71%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGNC icon
251
AGNC Investment
AGNC
$11.8B
$157K 0.03%
8,372
-3,085
-27% -$58.5K
QQQ icon
252
Invesco QQQ Trust
QQQ
$474B
$154K 0.03%
978
-71
-7% -$11.7K
BDX icon
253
Becton Dickinson
BDX
$50.6B
$153K 0.03%
738
+18
+3% +$3.94K
SSNC icon
254
SS&C Technologies
SSNC
$19.1B
$150K 0.03%
2,909
+115
+4% +$5.7K
DLR icon
255
Digital Realty Trust
DLR
$66.5B
$148K 0.03%
1,418
+817
+136% +$86.2K
BITA
256
DELISTED
Bitauto Holdings Limited
BITA
$145K 0.03%
+7,000
New +$218K
TSRO
257
DELISTED
TESARO, Inc.
TSRO
$141K 0.03%
2,441
+499
+26% +$32.1K
VWOB icon
258
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.25B
$140K 0.03%
+1,800
New +$142K
MLCO icon
259
Melco Resorts & Entertainment
MLCO
$1.76B
$140K 0.03%
+5,000
New +$140K
CWB icon
260
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.5B
$140K 0.03%
2,740
-124
-4% -$6.46K
TGTX icon
261
TG Therapeutics
TGTX
$8.12B
$139K 0.03%
+9,834
New +$126K
XYL icon
262
Xylem
XYL
$25.1B
$137K 0.03%
1,806
-22,672
-93% -$1.68M
XLF icon
263
State Street Financial Select Sector SPDR ETF
XLF
$54.4B
$136K 0.03%
5,020
-1,347
-21% -$38.8K
ONCE
264
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$136K 0.03%
+2,098
New +$121K
ATVI
265
DELISTED
Activision Blizzard
ATVI
$135K 0.03%
2,087
-953
-31% -$67.3K
NOW icon
266
ServiceNow
NOW
$147B
$135K 0.03%
4,225
-400
-9% -$12.3K
ADAP
267
DELISTED
Adaptimmune Therapeutics
ADAP
$135K 0.03%
+13,372
New +$117K
ACN icon
268
Accenture
ACN
$118B
$134K 0.03%
904
-10,501
-92% -$1.66M
TEO icon
269
Telecom Argentina
TEO
$6B
$132K 0.03%
4,286
+4,184
+4,102% +$147K
CLR
270
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$130K 0.03%
2,274
+132
+6% +$7.12K
TXN icon
271
Texas Instruments
TXN
$241B
$128K 0.03%
1,256
+72
+6% +$7.8K
ALXN
272
DELISTED
Alexion Pharmaceuticals
ALXN
$127K 0.03%
1,155
+736
+176% +$88K
BPMC
273
DELISTED
Blueprint Medicines
BPMC
$127K 0.03%
+1,462
New +$126K
BA icon
274
PUT
Boeing
BA
$166B
$126K 0.03%
100
-400
-80% -$135K
CAH icon
275
Cardinal Health
CAH
$54.1B
$126K 0.03%
2,034
-11,352
-85% -$779K

Similar funds

Exane Derivatives's Q1 2018 Portfolio in Review

As of Q1 2018, Exane Derivatives held 671 positions worth $500M, down 14% from $581M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Exane Derivatives withdrew a net $34.9M in Q1 2018, closing 46 positions and reducing 213 holdings. Its most notable exit was UBS Group, an estimated $34.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 39% a quarter earlier, followed by Communication Services and Materials.

Against the trend, Exane Derivatives opened a new position in AB InBev worth $5.29M.

  • Exane Derivatives's largest Q1 2018 buy was AB InBev: 48,192 shares worth $5.29M.
  • Exane Derivatives added most to PepsiCo in Q1 2018, an estimated $9.36M increase.
  • Exane Derivatives's biggest Q1 2018 reduction was iShares China Large-Cap ETF, cutting an estimated $43.3M.
  • Exane Derivatives fully exited UBS Group in Q1 2018, selling an estimated $34.3M.
  • Exane Derivatives's ten largest holdings make up 34% of its $500M portfolio in Q1 2018.
  • Exane Derivatives opened 64 new positions and closed 46 in Q1 2018.
  • Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $500M.

Based on Exane Derivatives's 13F filing for Q1 2018, filed 30 Apr 2018.